Oral ketamine vs placebo for anxiety in pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism, Mental health clinical trials.
This early study tests whether an oral form of ketamine can reduce anxiety symptoms in people living with pancreatic cancer. Participants are compared with a placebo (inactive pill) to see if ketamine is safe and potentially helpful for anxiety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) and can sign informed consent.
- You have been diagnosed with pancreatic cancer and started cancer treatment (surgery, radiation, chemo, immunotherapy, or other targeted therapy) within the last 12 weeks.
- You currently have moderate to severe anxiety, based on a standard anxiety questionnaire.
- Your liver tests are adequate on screening.
- If you take anxiety-focused antidepressants (like SSRIs), the dose must be stable for at least 12 weeks before starting this study.
- You agree to avoid alcohol during the study and follow driving/unsafe-activity limits after each dose until the next day after a good night’s sleep.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of ketamine nasal spray can help reduce depression and anxiety in people living with advanced cancer. If you have a progressive cancer and are feeling down or anxious, you might benefit from this quick treatment.
This trial tests whether a medicine called esketamine (given during anesthesia) can help reduce anxiety, sadness, or other negative emotions that often occur before and after breast cancer surgery. This could help you feel better emotionally during your recovery.
This trial tests whether esketamine, an anesthetic, can help reduce severe depression symptoms in women having breast cancer surgery. You may qualify if you have severe depression before surgery.
This trial tests whether giving a medication called esketamine during breast cancer surgery can help reduce negative emotions like depression and anxiety after surgery. It is for women who already have mild to severe depression symptoms.
This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.
This trial studies how ketamine affects the brain in people dealing with suicidal thoughts or an active suicide crisis. It uses questionnaires, consent testing, and brain imaging to look for biological changes that may relate to symptom improvement.
Hear when a new Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.